{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-07-12T03:48:31.944932+00:00","company":{"ticker":"GRDX","cik":1604191,"company_name":"GridAI Technologies Corp."},"pagination":{"limit":100,"returned":82,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{"contract_counterparty":[{"display_name":"Roth Capital Partners, LLC","detail":"underwriting","count":3,"first_seen":"2023-07-21T23:59:59+00:00","last_seen":"2024-05-13T23:59:59+00:00","evidence_fact_ids":[47174,69695,129449]},{"display_name":"purchasers identified therein","detail":"equity_purchase","count":2,"first_seen":"2026-05-14T20:01:34+00:00","last_seen":"2026-05-14T20:01:34+00:00","evidence_fact_ids":[102980,102981]},{"display_name":"1396974 BC Ltd.","detail":"settlement","count":1,"first_seen":"2026-05-20T20:06:01+00:00","last_seen":"2026-05-20T20:06:01+00:00","evidence_fact_ids":[95568]},{"display_name":"Fortis Advisors LLC and certain individuals","detail":"settlement","count":1,"first_seen":"2022-12-02T23:59:59+00:00","last_seen":"2022-12-02T23:59:59+00:00","evidence_fact_ids":[193366]},{"display_name":"ImmunogenX","detail":"merger","count":1,"first_seen":"2024-03-14T23:59:59+00:00","last_seen":"2024-03-14T23:59:59+00:00","evidence_fact_ids":[67188]},{"display_name":"Sanofi","detail":"license","count":1,"first_seen":"2023-09-14T23:59:59+00:00","last_seen":"2023-09-14T23:59:59+00:00","evidence_fact_ids":[113378]}],"lender":[{"display_name":"1396974 BC Ltd.","detail":"revolving_credit","count":2,"first_seen":"2025-02-06T23:59:59+00:00","last_seen":"2026-04-24T23:59:59+00:00","evidence_fact_ids":[29457,154892]},{"display_name":"Mattress Liquidators Inc.","detail":"revolving_credit","count":1,"first_seen":"2025-05-14T23:59:59+00:00","last_seen":"2025-05-14T23:59:59+00:00","evidence_fact_ids":[93440]}],"ma_counterparty":[{"display_name":"1396974 BC Ltd.","detail":"change_of_control","count":1,"first_seen":"2025-02-06T23:59:59+00:00","last_seen":"2025-02-06T23:59:59+00:00","evidence_fact_ids":[96399]},{"display_name":"ImmunogenX, Inc.","detail":"acquisition","count":1,"first_seen":"2024-03-14T23:59:59+00:00","last_seen":"2024-03-14T23:59:59+00:00","evidence_fact_ids":[67189]},{"display_name":"ImmunogenX, LLC and each of the individuals or entities who are the former shareholders of ImmunogenX, Inc.","detail":"disposition","count":1,"first_seen":"2026-01-07T23:59:59+00:00","last_seen":"2026-01-07T23:59:59+00:00","evidence_fact_ids":[25479]}]},"facts":[{"fact_type":"material_agreement","fact_key":"249740613edb18a79bae9b05af987f21c23bcec7","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2026-05-20T20:06:01+00:00","payload":{"action":"entry","agreement_name":"Debt Settlement and Subscription Agreement","agreement_type":"settlement","counterparty":"1396974 BC Ltd.","effective_date":"2026-05-14","item_codes_triggered":["1.01"],"value_text":null},"claim":"GridAI Technologies Corp. entered into Debt Settlement and Subscription Agreement with 1396974 BC Ltd. (effective 2026-05-14).","evidence_excerpt":"On May 14, 2026, the Company and the Lender entered into a Debt Settlement and Subscription Agreement (the “Settlement Agreement”)","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-26-064500","anchor_url":"https://secwatch.observer/filing/0001104659-26-064500#claim-249740613edb18a79bae9b05af987f21c23bcec7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465926064500/0001104659-26-064500-index.htm"},{"fact_type":"material_agreement","fact_key":"7f577694cf536daf8c9fce369b332e385a43bb37","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2026-05-14T20:01:34+00:00","payload":{"action":"entry","agreement_name":"Additional Purchase Agreement","agreement_type":"equity_purchase","counterparty":"purchasers identified therein","effective_date":"2026-05-11","item_codes_triggered":["1.01"],"value_text":"approximately $5,250,000"},"claim":"GridAI Technologies Corp. entered into Additional Purchase Agreement with purchasers identified therein valued at approximately $5,250,000 (effective 2026-05-11).","evidence_excerpt":"On May 11, 2026, the Company entered into a securities purchase agreement (the “Additional Purchase Agreement”) with the purchasers identified therein (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”) pursuant to which the Company will sell to the Purchasers in private placements an aggregate of (i) 87,260 shares of common stock, (ii) pre-funded warrants to purchase up to an aggregate of 1,745,199 shares of common stock (the “Pre-Funded Warrants”) and (iii) common stock purchase warrants to purchase up to an aggregate of 1,832,459 shares of common stock (the “Common Warrants”) for gross proceeds to the Company of approximately $5,250,000.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-26-061136","anchor_url":"https://secwatch.observer/filing/0001104659-26-061136#claim-7f577694cf536daf8c9fce369b332e385a43bb37","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465926061136/0001104659-26-061136-index.htm"},{"fact_type":"material_agreement","fact_key":"25f9bf213bbadacf8c2136ffd4100da34f9e1b77","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2026-05-14T20:01:34+00:00","payload":{"action":"entry","agreement_name":"Purchase Agreements","agreement_type":"equity_purchase","counterparty":"purchasers identified therein","effective_date":"2026-05-08","item_codes_triggered":["1.01"],"value_text":"approximately $2,540,000"},"claim":"GridAI Technologies Corp. entered into Purchase Agreements with purchasers identified therein valued at approximately $2,540,000 (effective 2026-05-08).","evidence_excerpt":"On May 8, 2026, May 11, 2026 and May 12, 2026, GridAI Technologies Corp. (the “Company”) entered into securities purchase agreements (the “Purchase Agreements”) with purchasers identified therein (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”) pursuant to which the Company agreed to sell to the Purchasers in private placements an aggregate of (i) 74,000 shares of common stock, (ii) pre-funded warrants to purchase up to an aggregate of 1,196,001 shares of common stock (the “Pre-Funded Warrants”) and (iii) common stock purchase warrants to purchase up to an aggregate of 1,270,001 shares of common stock (the “Common Warrants”) for gross proceeds to the Company of approximately $2,540,000.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-26-061136","anchor_url":"https://secwatch.observer/filing/0001104659-26-061136#claim-25f9bf213bbadacf8c2136ffd4100da34f9e1b77","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465926061136/0001104659-26-061136-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"d30f6afde88c25eaf0af1b51a26a4877f1d9437f","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2026-04-28T23:59:59+00:00","payload":{"company_response":"Company intends to file 10-K as soon as possible and submit a plan to regain compliance.","compliance_status":"plan_due","cure_deadline":"2026-10-12","deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"timely filing of periodic financial reports","notice_date":"2026-04-22","notice_type":"deficiency_notice","plan_due_date":"2026-06-22","raw_rule_text":null,"reported_value":null,"rule_numbers":["5250(c)(1)"],"rules_cited_in_text":true},"claim":"GridAI Technologies Corp. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"April 22, 2026, GridAI Technologies Corp. (the\n“Company”) received a letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market\nLLC (“Nasdaq”) indicating that the Company was not in compl","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-26-050499","anchor_url":"https://secwatch.observer/filing/0001104659-26-050499#claim-d30f6afde88c25eaf0af1b51a26a4877f1d9437f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465926050499/0001104659-26-050499-index.htm"},{"fact_type":"debt_financing","fact_key":"03163e3f14e56c09f3fd5f086350c6f989609cdd","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2026-04-24T23:59:59+00:00","payload":{"counterparty":"1396974 BC Ltd.","effective_date":"2026-04-01","event":"acceleration","instrument_type":"revolving_credit","interest_rate_text":null,"item_codes_triggered":["2.04"],"maturity_text":"January 31, 2026","principal_text":"$1,014,675"},"claim":"GridAI Technologies Corp. faced acceleration on revolving credit of $1,014,675 with 1396974 BC Ltd. maturing January 31, 2026.","evidence_excerpt":"On April 1, 2026, the Company received a demand letter from the Lender’s counsel, asserting that the Company is in default of the Revolving Loan Agreement as the Maturity Date has passed and the amounts due under the Revolving Loan Agreement have not been repaid, and demanding the Company to pay a total sum of $1,014,675, which includes the principal amounts received by the Company ($700,000), interest and a 20% increase of these amounts due to the default pursuant to the terms of Revolving Loan Agreement.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-26-048549","anchor_url":"https://secwatch.observer/filing/0001104659-26-048549#claim-03163e3f14e56c09f3fd5f086350c6f989609cdd","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465926048549/0001104659-26-048549-index.htm"},{"fact_type":"ma_transaction","fact_key":"bd4d01f95d637ff7f3b6cf2e55854108c05c4b6c","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2026-01-07T23:59:59+00:00","payload":{"action":"disposition","closing_date":"2025-12-31","consideration_text":null,"counterparty":"ImmunogenX, LLC and each of the individuals or entities who are the former shareholders of ImmunogenX, Inc.","effective_date":"2025-12-31","item_codes_triggered":["2.01"]},"claim":"GridAI Technologies Corp. completed a disposition involving ImmunogenX, LLC and each of the individuals or entities who are the former shareholders of ImmunogenX, Inc. (closed 2025-12-31).","evidence_excerpt":"On December 31, 2025, the Company, Immuno LLC and the Shareholders completed the transactions contemplated by the Rescission Agreement, as amended by the Rescission Agreement Amendment (the “Transaction”), including the transfer by the Coamny to the Shareholders of all of the issued and outstanding membership interests of Immuno LLC held by the Company.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-26-001755","anchor_url":"https://secwatch.observer/filing/0001104659-26-001755#claim-bd4d01f95d637ff7f3b6cf2e55854108c05c4b6c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465926001755/0001104659-26-001755-index.htm"},{"fact_type":"governance_change","fact_key":"fa8d2b3184c41aa8b1330c7c845244d057f186c9","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2025-12-04T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2025-12-01","item_codes_triggered":["5.03"],"summary_text":"Company amended its Certificate of Incorporation to change name from Entero Therapeutics, Inc. to GridAI Technologies Corp."},"claim":"GridAI Technologies Corp.: Company amended its Certificate of Incorporation to change name from Entero Therapeutics, Inc. to GridAI Technologies Corp (effective 2025-12-01).","evidence_excerpt":"The Company amended its Amended and Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”), to effect a change of the Company’s name from “Entero Therapeutics, Inc.” to “GridAI Technologies Corp.” (the “Name Change”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-25-118524","anchor_url":"https://secwatch.observer/filing/0001104659-25-118524#claim-fa8d2b3184c41aa8b1330c7c845244d057f186c9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925118524/0001104659-25-118524-index.htm"},{"fact_type":"debt_financing","fact_key":"52ad511d209bd2ec8c1552fdae89bf83580bf421","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2025-10-22T23:59:59+00:00","payload":{"counterparty":"an investor","effective_date":"2025-10-17","event":"incurrence","instrument_type":"other","interest_rate_text":"does not bear interest","item_codes_triggered":["2.03"],"maturity_text":"one year and one day after its date of issuance","principal_text":"$500,000"},"claim":"GridAI Technologies Corp. incurred debt of $500,000 with an investor at does not bear interest maturing one year and one day after its date of issuance.","evidence_excerpt":"Initial Closing took place on October 17, 2025, pursuant to which the Company sold to the Investor: (i) a Note in the principal amount of $500,000","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-25-101519","anchor_url":"https://secwatch.observer/filing/0001104659-25-101519#claim-52ad511d209bd2ec8c1552fdae89bf83580bf421","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925101519/0001104659-25-101519-index.htm"},{"fact_type":"governance_change","fact_key":"d1312d229ffdaa970bc0b49970e760c12a44a719","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2025-10-06T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2025-10-01","item_codes_triggered":["5.03"],"summary_text":"Filed Certificate of Designation creating Series H Preferred Stock."},"claim":"GridAI Technologies Corp.: Filed Certificate of Designation creating Series H Preferred Stock (effective 2025-10-01).","evidence_excerpt":"On October 1, 2025, the Company filed the Certificate of Designation with the Secretary of State of the State of Delaware.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-25-097138","anchor_url":"https://secwatch.observer/filing/0001104659-25-097138#claim-d1312d229ffdaa970bc0b49970e760c12a44a719","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925097138/0001104659-25-097138-index.htm"},{"fact_type":"governance_change","fact_key":"996966f3de7b65147aef94bdb9f46c165968ee5e","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2025-08-15T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2025-08-18","item_codes_triggered":["5.03"],"summary_text":"Amended certificate of incorporation to effect a 1-for-3 reverse stock split"},"claim":"GridAI Technologies Corp.: Amended certificate of incorporation to effect a 1-for-3 reverse stock split (effective 2025-08-18).","evidence_excerpt":"On August 14, 2025, the Company filed with the Secretary of State of the State of Delaware the Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) to effect the Reverse Stock Split.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-25-079322","anchor_url":"https://secwatch.observer/filing/0001104659-25-079322#claim-996966f3de7b65147aef94bdb9f46c165968ee5e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925079322/0001104659-25-079322-index.htm"},{"fact_type":"debt_financing","fact_key":"14a5607cd501e1fd4c7d77cd35a1bd7304a8e39a","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2025-05-14T23:59:59+00:00","payload":{"counterparty":"Mattress Liquidators Inc.","effective_date":"2025-04-09","event":"amendment","instrument_type":"revolving_credit","interest_rate_text":null,"item_codes_triggered":["2.03"],"maturity_text":"April 9, 2028","principal_text":"$2,436,338.30"},"claim":"GridAI Technologies Corp. amended revolving credit of $2,436,338.30 with Mattress Liquidators Inc. maturing April 9, 2028.","evidence_excerpt":"enter into amended and restated loan documents (collectively, the “Amended and Restated Loan Documents”) dated April 9,\n2025 which provide for, among others, a revolving loan of $2,436,338.30 (the “Commitment”) to ImmunogenX, LLC, to be repaid\nand the principal amount thereof reborrowed before the earliest of: (i) April 9, 2028; (ii) the date ImmunogenX, LLC prepays","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-25-048544","anchor_url":"https://secwatch.observer/filing/0001104659-25-048544#claim-14a5607cd501e1fd4c7d77cd35a1bd7304a8e39a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925048544/0001104659-25-048544-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"c75dcc0915c7daa1772f2ee3c17e6ba92d1fe17c","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2025-04-14T23:59:59+00:00","payload":{"company_response":"intends to submit a plan to regain compliance","compliance_status":"plan_due","cure_deadline":"2025-10-08","deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"$2.5 million","notice_date":"2025-04-11","notice_type":"deficiency_notice","plan_due_date":"2025-05-26","raw_rule_text":"Listing Rule 5550(b)(1)","reported_value":"($3,876,738)","rule_numbers":["5550(b)(1)"],"rules_cited_in_text":true},"claim":"GridAI Technologies Corp. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"April 11, 2025, Entero Therapeutics, Inc. (the\n“Company”) received a letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market\nLLC (“Nasdaq”) indicating that the Company was not in compliance with the minimum stockholders’ equity requirement for\ncontinued listing on The Nasdaq Capital Market, under Listing Rule 5550(b)(1), because the Company’s stockholders’ equity\nof ($3,876,738) as reported in the Company’s Annual Report on Form 10-K for the period ended December 31, 2024 was below the required\nminimum of $2.5 million, and because, as of April 10, 2025 the C","confidence":0.98,"filing_url":"https://secwatch.observer/filing/0001104659-25-034689","anchor_url":"https://secwatch.observer/filing/0001104659-25-034689#claim-c75dcc0915c7daa1772f2ee3c17e6ba92d1fe17c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925034689/0001104659-25-034689-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"c7804bd53cbda05d0ca8e3f569f78ca556dfd68e","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2025-03-07T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"plan_due","cure_deadline":"2025-06-30","deficiency_type":"shareholders","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2025-01-07","notice_type":"noncompliance_notice","plan_due_date":"2025-02-21","raw_rule_text":null,"reported_value":null,"rule_numbers":["5620(a)"],"rules_cited_in_text":true},"claim":"GridAI Technologies Corp. received a nasdaq noncompliance notice notice regarding shareholders (rules 5620(a)).","evidence_excerpt":"January 7, 2025, a formal\nletter from Nasdaq notifying the Company that it did not comply with Nsadaq Listing Rule 5620(a) (the “Annual Meeting Rule”),\nwhich requires that it hold an annual meeting of shareholders within twelve months of the end of the Company’s fiscal year end. On February 21, 2025, the Company submitted to\nthe Staff a plan of compliance which described the circumstances under which it became noncompliant with the Annual Meeting Rule and the\nCompany’s plan with which it will regain compliance. The Staff in its letter dated March 3, 2025 determined to grant the Company\nan exte","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-25-021728","anchor_url":"https://secwatch.observer/filing/0001104659-25-021728#claim-c7804bd53cbda05d0ca8e3f569f78ca556dfd68e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925021728/0001104659-25-021728-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"028baaa74432b6df6fbd05b8e20c7b22b38dcb23","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2025-03-07T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"extension_granted","cure_deadline":"2025-09-01","deficiency_type":"minimum_bid_price","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":null,"notice_date":"2025-03-07","notice_type":"extension_granted","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5810(c)(3)(A)"],"rules_cited_in_text":true},"claim":"GridAI Technologies Corp. received a nasdaq extension granted notice regarding minimum bid price (rules 5810(c)(3)(A)).","evidence_excerpt":"s days, the Company is not currently in compliance with the requirement\nto maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing\nRule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company was\nprovided 180 days, or until March 5, 2025, to regain compliance with the Minimum Bid Price Requirement. On March 6, 2025, the Company received a letter\nfrom Nasdaq (the “Extension Notice”) advising that the Company has been granted a 180-day extension, or until Septemb","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-25-021728","anchor_url":"https://secwatch.observer/filing/0001104659-25-021728#claim-028baaa74432b6df6fbd05b8e20c7b22b38dcb23","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925021728/0001104659-25-021728-index.htm"},{"fact_type":"executive_change","fact_key":"dd0a122a86","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2025-03-07T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-03-07","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Anna Skowron was appointed as Chief Financial Officer at GridAI Technologies Corp..","evidence_excerpt":"on March 3, 2025, the Company appointed Ms. Anna Skowron as Chief Financial Officer of the Company, effective as of March 7, 2025","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-25-021728","anchor_url":"https://secwatch.observer/filing/0001104659-25-021728#claim-dd0a122a86","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925021728/0001104659-25-021728-index.htm"},{"fact_type":"executive_change","fact_key":"3485c5d176","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2025-03-07T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2025-03-07","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":"Anna Skowron","successor_named":true},"claim":"Sarah Romano resigned as Chief Financial Officer at GridAI Technologies Corp..","evidence_excerpt":"On March 3, 2025, Ms. Sarah Romano informed the Company of her resignation as Chief Financial Officer of the Company, effective as of March 7, 2025.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-25-021728","anchor_url":"https://secwatch.observer/filing/0001104659-25-021728#claim-3485c5d176","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925021728/0001104659-25-021728-index.htm"},{"fact_type":"executive_change","fact_key":"17f669daf4","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2025-02-14T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-02-12","interim":true,"role":"Interim Chief Executive Officer and Chairman of the Board","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Richard Joel Paolone was appointed as Interim Chief Executive Officer and Chairman of the Board at GridAI Technologies Corp..","evidence_excerpt":"On February 12, 2025, Richard Joel Paolone was appointed to serve as Interim Chief Executive Officer of the Company and Chairman of the Board, effective immediately.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001104659-25-014165","anchor_url":"https://secwatch.observer/filing/0001104659-25-014165#claim-17f669daf4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925014165/0001104659-25-014165-index.htm"},{"fact_type":"executive_change","fact_key":"f8aa5090a6","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2025-02-14T23:59:59+00:00","payload":{"action":"terminated","action_category":"departure","departure_tone":"termination","effective_date":"2025-02-12","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":"Richard Joel Paolone","successor_named":true},"claim":"James Sapirstein was terminated as Chief Executive Officer at GridAI Technologies Corp..","evidence_excerpt":"On February 12, 2025, the Board of Directors (the “Board”) of Entero Therapeutics, Inc. (the “Company”) terminated James Sapirstein as Chief Executive Officer of the Company, without cause, effective immediately.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001104659-25-014165","anchor_url":"https://secwatch.observer/filing/0001104659-25-014165#claim-f8aa5090a6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925014165/0001104659-25-014165-index.htm"},{"fact_type":"debt_financing","fact_key":"6a9d73cd0ff124426b76396fb280a432ff674082","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2025-02-06T23:59:59+00:00","payload":{"counterparty":"1396974 BC Ltd.","effective_date":"2025-01-31","event":"incurrence","instrument_type":"revolving_credit","interest_rate_text":"18% per annum","item_codes_triggered":["2.03"],"maturity_text":"January 31, 2026","principal_text":"$2,000,000"},"claim":"GridAI Technologies Corp. incurred revolving credit of $2,000,000 with 1396974 BC Ltd. at 18% per annum maturing January 31, 2026.","evidence_excerpt":"the Company. Pursuant to and under\nthe terms of the Revolving Loan Agreement, the Company issued to the Lender a revolving note dated January 27, 2025 in the principal amount\nof $2,000,000 (the “Revolving Note” and such amount, the “Total Outstanding Amount”). This transaction is referred\nto as the “Financing.” The Company shall use the proceeds from the Financing","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-25-010132","anchor_url":"https://secwatch.observer/filing/0001104659-25-010132#claim-6a9d73cd0ff124426b76396fb280a432ff674082","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925010132/0001104659-25-010132-index.htm"},{"fact_type":"ma_transaction","fact_key":"ab35fa5e6575580d464675e8ca6c0319de951307","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2025-02-06T23:59:59+00:00","payload":{"action":"change_of_control","closing_date":null,"consideration_text":null,"counterparty":"1396974 BC Ltd.","effective_date":"2025-01-31","item_codes_triggered":["5.01"]},"claim":"GridAI Technologies Corp. underwent a change of control involving 1396974 BC Ltd..","evidence_excerpt":"Upon the closing of the Financing, the Lender acquired control of the Company by appointing a majority of the Company’s Board of Directors.","confidence":0.7,"filing_url":"https://secwatch.observer/filing/0001104659-25-010132","anchor_url":"https://secwatch.observer/filing/0001104659-25-010132#claim-ab35fa5e6575580d464675e8ca6c0319de951307","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925010132/0001104659-25-010132-index.htm"},{"fact_type":"executive_change","fact_key":"a8f04968f6","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2025-02-06T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-02-03","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Richard Joel Paolone was appointed as director at GridAI Technologies Corp..","evidence_excerpt":"the Company’s Board of Directors appointed Manpreet Uppal, Alson Niu and Richard Joel Paolone as directors of the Company","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-25-010132","anchor_url":"https://secwatch.observer/filing/0001104659-25-010132#claim-a8f04968f6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925010132/0001104659-25-010132-index.htm"},{"fact_type":"executive_change","fact_key":"48ecc975d8","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2025-02-06T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-02-03","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Alson Niu was appointed as director at GridAI Technologies Corp..","evidence_excerpt":"the Company’s Board of Directors appointed Manpreet Uppal, Alson Niu and Richard Joel Paolone as directors of the Company","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-25-010132","anchor_url":"https://secwatch.observer/filing/0001104659-25-010132#claim-48ecc975d8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925010132/0001104659-25-010132-index.htm"},{"fact_type":"executive_change","fact_key":"514ddccf42","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2025-02-06T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-02-03","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Manpreet Uppal was appointed as director at GridAI Technologies Corp..","evidence_excerpt":"the Company’s Board of Directors appointed Manpreet Uppal, Alson Niu and Richard Joel Paolone as directors of the Company","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-25-010132","anchor_url":"https://secwatch.observer/filing/0001104659-25-010132#claim-514ddccf42","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925010132/0001104659-25-010132-index.htm"},{"fact_type":"executive_change","fact_key":"d0726fa8d6","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2025-02-06T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"not_disclosed","effective_date":"2025-02-03","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"James Sapirstein resigned as director at GridAI Technologies Corp..","evidence_excerpt":"On February 3, 2025 (i) each of Timothy Ramdeen, Alastair Riddell and James Sapirstein resigned as directors of the Company","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-25-010132","anchor_url":"https://secwatch.observer/filing/0001104659-25-010132#claim-d0726fa8d6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925010132/0001104659-25-010132-index.htm"},{"fact_type":"executive_change","fact_key":"df7a19f31e","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2025-02-06T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"not_disclosed","effective_date":"2025-02-03","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Alastair Riddell resigned as director at GridAI Technologies Corp..","evidence_excerpt":"On February 3, 2025 (i) each of Timothy Ramdeen, Alastair Riddell and James Sapirstein resigned as directors of the Company","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-25-010132","anchor_url":"https://secwatch.observer/filing/0001104659-25-010132#claim-df7a19f31e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925010132/0001104659-25-010132-index.htm"},{"fact_type":"executive_change","fact_key":"2a9f8a12c1","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2025-02-06T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"not_disclosed","effective_date":"2025-02-03","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Timothy Ramdeen resigned as director at GridAI Technologies Corp..","evidence_excerpt":"On February 3, 2025 (i) each of Timothy Ramdeen, Alastair Riddell and James Sapirstein resigned as directors of the Company","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-25-010132","anchor_url":"https://secwatch.observer/filing/0001104659-25-010132#claim-2a9f8a12c1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925010132/0001104659-25-010132-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"ce52b6076e297d0bf0cd6913ff58a92e6defa8d2","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2025-01-13T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":null,"deficiency_type":"shareholders","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2025-01-07","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5620(a)"],"rules_cited_in_text":true},"claim":"GridAI Technologies Corp. received a nasdaq deficiency notice notice regarding shareholders (rules 5620(a)).","evidence_excerpt":"le or Standard; Transfer of Listing. On January\n7, 2025, Entero Therapeutics, Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications\ndepartment of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing\nRule 5620(a), due to the Company not holding an annual meeting of stockholders in 2024 within one year of the Company’s\n2023 fiscal year end. The Company has until February 21, 2025, which is 45 days from the date of the Notice, to submit a plan to regain\ncompliance and, if Nasdaq accepts the plan, it ma","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-25-003048","anchor_url":"https://secwatch.observer/filing/0001104659-25-003048#claim-ce52b6076e297d0bf0cd6913ff58a92e6defa8d2","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925003048/0001104659-25-003048-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"ce52b6076e297d0bf0cd6913ff58a92e6defa8d2","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2025-01-13T23:59:59+00:00","payload":{"company_response":"intends_to_hold_annual_meeting","compliance_status":"plan_due","cure_deadline":null,"deficiency_type":"shareholders","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":null,"notice_date":"2025-01-07","notice_type":"deficiency_notice","plan_due_date":"2025-02-21","raw_rule_text":null,"reported_value":null,"rule_numbers":["5620(a)"]},"claim":"GridAI Technologies Corp. received a nasdaq deficiency notice notice regarding shareholders (rules 5620(a)).","evidence_excerpt":"Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing\nRule 5620(a), due to the Company not holding an annual meeting of stockholders in 2024 within one year of the Compa","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-25-003048","anchor_url":"https://secwatch.observer/filing/0001104659-25-003048#claim-ce52b6076e297d0bf0cd6913ff58a92e6defa8d2","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925003048/0001104659-25-003048-index.htm"},{"fact_type":"executive_change","fact_key":"cad23b7aee","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2024-08-22T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-08-16","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Chaitan Khosla resigned as Director at GridAI Technologies Corp..","evidence_excerpt":"On August 16, 2024, Chaitan Khosla resigned as a member of the Board of Directors (the “Board”) of Entero Therapeutics, Inc. (the “Company”), effective immediately.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001104659-24-092061","anchor_url":"https://secwatch.observer/filing/0001104659-24-092061#claim-cad23b7aee","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924092061/0001104659-24-092061-index.htm"},{"fact_type":"executive_change","fact_key":"70cae267e4","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2024-08-15T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-08-09","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Timothy R. Ramdeen was appointed as Director at GridAI Technologies Corp..","evidence_excerpt":"appointed Timothy R. Ramdeen as a member of the Board.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-24-089923","anchor_url":"https://secwatch.observer/filing/0001104659-24-089923#claim-70cae267e4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924089923/0001104659-24-089923-index.htm"},{"fact_type":"executive_change","fact_key":"601ff34c52","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2024-08-07T23:59:59+00:00","payload":{"action":"terminated","action_category":"departure","departure_tone":"termination","effective_date":"2024-08-02","interim":false,"role":"President","role_category":"president","successor_name":null,"successor_named":false},"claim":"Jack Syage was terminated as President at GridAI Technologies Corp..","evidence_excerpt":"and (ii) the offer letter, dated March 13, 2024, by and between the Company and President Jack Syage","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-24-086824","anchor_url":"https://secwatch.observer/filing/0001104659-24-086824#claim-601ff34c52","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924086824/0001104659-24-086824-index.htm"},{"fact_type":"executive_change","fact_key":"9f6a81dc7c","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2024-08-07T23:59:59+00:00","payload":{"action":"terminated","action_category":"departure","departure_tone":"termination","effective_date":"2024-08-02","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"James Sapirstein was terminated as Chief Executive Officer at GridAI Technologies Corp..","evidence_excerpt":"the Board approved the termination of (i) the employment agreement, dated October 8, 2019, by and between the Company and Chief Executive Officer James Sapirstein","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-24-086824","anchor_url":"https://secwatch.observer/filing/0001104659-24-086824#claim-9f6a81dc7c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924086824/0001104659-24-086824-index.htm"},{"fact_type":"executive_change","fact_key":"d4f9e9d485","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2024-08-07T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-08-02","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Terry Coelho resigned as Director at GridAI Technologies Corp..","evidence_excerpt":"On August 2, 2024, Charles J. Casamento and Terry Coelho resigned as members of the Board of the Company, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-24-086824","anchor_url":"https://secwatch.observer/filing/0001104659-24-086824#claim-d4f9e9d485","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924086824/0001104659-24-086824-index.htm"},{"fact_type":"executive_change","fact_key":"8f5329cd0f","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2024-08-07T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-08-02","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Charles J. Casamento resigned as Director at GridAI Technologies Corp..","evidence_excerpt":"On August 2, 2024, Charles J. Casamento and Terry Coelho resigned as members of the Board of the Company, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-24-086824","anchor_url":"https://secwatch.observer/filing/0001104659-24-086824#claim-8f5329cd0f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924086824/0001104659-24-086824-index.htm"},{"fact_type":"executive_change","fact_key":"99e321776f","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2024-07-23T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-07-17","interim":false,"role":"Chief Scientific Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Jack Syage resigned as Chief Scientific Officer at GridAI Technologies Corp..","evidence_excerpt":"Dr. Jack Syage, the Company’s Chief Scientific Officer, President and member of the Board, whereby he tendered his resignation from the role of Chief Scientific Officer of the Company, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-24-081888","anchor_url":"https://secwatch.observer/filing/0001104659-24-081888#claim-99e321776f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924081888/0001104659-24-081888-index.htm"},{"fact_type":"executive_change","fact_key":"6f3eb0c2cb","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2024-06-20T23:59:59+00:00","payload":{"action":"transitioned","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2024-06-17","interim":false,"role":"Chief Scientific Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Jack Syage changed role as Chief Scientific Officer at GridAI Technologies Corp..","evidence_excerpt":"transitioned Dr. Syage from the role of Chief Operating Officer to the newly appointed role of Chief Scientific Officer, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-24-073418","anchor_url":"https://secwatch.observer/filing/0001104659-24-073418#claim-6f3eb0c2cb","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924073418/0001104659-24-073418-index.htm"},{"fact_type":"governance_change","fact_key":"eba0aa87be84d2d4057ec2a383ca6027082dd055","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2024-05-16T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2024-05-17","item_codes_triggered":["5.03"],"summary_text":"Company changed its corporate name from First Wave BioPharma, Inc. to Entero Therapeutics, Inc. via amendment to Amended and Restated Certificate of Incorporation."},"claim":"GridAI Technologies Corp.: Company changed its corporate name from First Wave BioPharma, Inc. to Entero Therapeutics, Inc. via amendment to Amended and Restated Certificate of Incorporation (effective 2024-05-17).","evidence_excerpt":"On May 15, 2024, First Wave BioPharma, Inc. (the “Company”) filed an amendment to its Amended and Restated Certificate of Incorporation with the Secretary of State of Delaware to change its corporate name from \"First Wave BioPharma, Inc.\" to \"Entero Therapeutics, Inc.\" (the \"Name Change Amendment\"). Pursuant ot the Name Change Amendment, this name change is effective as of May 17, 2024.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-24-062263","anchor_url":"https://secwatch.observer/filing/0001104659-24-062263#claim-eba0aa87be84d2d4057ec2a383ca6027082dd055","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924062263/0001104659-24-062263-index.htm"},{"fact_type":"material_agreement","fact_key":"bdeb8bfb37d6e1b624cb01417d51b399ab30ae17","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2024-05-13T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Placement Agency Agreement","agreement_type":"underwriting","counterparty":"Roth Capital Partners, LLC","effective_date":"2024-05-10","item_codes_triggered":["1.01"],"value_text":null},"claim":"GridAI Technologies Corp. entered into Placement Agency Agreement with Roth Capital Partners, LLC (effective 2024-05-10).","evidence_excerpt":"On May 10, 2024, First Wave BioPharma, Inc. (the “Company”) entered into a placement agency agreement (the “Placement Agency Agreement”) with Roth Capital Partners, LLC (the “Placement Agent”)","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-24-060689","anchor_url":"https://secwatch.observer/filing/0001104659-24-060689#claim-bdeb8bfb37d6e1b624cb01417d51b399ab30ae17","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924060689/0001104659-24-060689-index.htm"},{"fact_type":"material_agreement","fact_key":"839e76bf8092ec375cfbedac335957f80f9e001c","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2024-05-13T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Purchase Agreement","agreement_type":"equity_purchase","counterparty":"certain purchasers","effective_date":"2024-05-10","item_codes_triggered":["1.01"],"value_text":"approximately $0.9 million"},"claim":"GridAI Technologies Corp. entered into Purchase Agreement with certain purchasers valued at approximately $0.9 million (effective 2024-05-10).","evidence_excerpt":"On May 10, 2024, First Wave BioPharma, Inc. (the “Company”) entered into a placement agency agreement (the “Placement Agency Agreement”) with Roth Capital Partners, LLC (the “Placement Agent”) and a securities purchase agreement (the “Purchase Agreement”) with certain purchasers","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-24-060689","anchor_url":"https://secwatch.observer/filing/0001104659-24-060689#claim-839e76bf8092ec375cfbedac335957f80f9e001c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924060689/0001104659-24-060689-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"aa0c933a165e711b01fcf76d133ee9dff007be5f","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2024-03-22T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":null,"deficiency_type":"shareholders","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2024-03-19","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5635(d)"],"rules_cited_in_text":true},"claim":"GridAI Technologies Corp. received a nasdaq deficiency notice notice regarding shareholders (rules 5635(d)).","evidence_excerpt":"March 19, 2024, the Company received a Letter of Reprimand (the “Letter”) from\nthe Staff in accordance with Nasdaq’s Listing Rule 5810(c)(4). The\nStaff’s determination relates to the offering and issuance by the Company (the “Offering”) of an aggregate of: (i) 610,000\nshares (the “Shares”) of common stock, par value $0.0001 per share (the “Common Stock”), of the Company, (ii)\npre-funded warrants (the “Pre-Funded Warrants”) to purchase up to an aggregate of 2,675,000 shares of Common Stock (the “Pre-Funded\nWarrant Shares”) and (iii) common warrants (the “Warrants”) to purchase up to an aggregat","confidence":0.92,"filing_url":"https://secwatch.observer/filing/0001104659-24-037932","anchor_url":"https://secwatch.observer/filing/0001104659-24-037932#claim-aa0c933a165e711b01fcf76d133ee9dff007be5f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924037932/0001104659-24-037932-index.htm"},{"fact_type":"governance_change","fact_key":"d0f9c8eb820613b52e6db730cd23bc6b4671c5ee","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2024-03-14T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2024-03-13","item_codes_triggered":["5.03"],"summary_text":"Filed Certificate of Designation for Series G Non-Voting Convertible Preferred Stock, establishing its preferences, rights, and limitations."},"claim":"GridAI Technologies Corp.: Filed Certificate of Designation for Series G Non-Voting Convertible Preferred Stock, establishing its preferences, rights, and limitations (effective 2024-03-13).","evidence_excerpt":"Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. Certificate of Designation On March 13, 2024, the Company filed a Certificate of Designation of Preferences, Rights and Limitations of the Series G Non-Voting Convertible Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware in connection with the Merger referenced in Item 1.01 above.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-24-034161","anchor_url":"https://secwatch.observer/filing/0001104659-24-034161#claim-d0f9c8eb820613b52e6db730cd23bc6b4671c5ee","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924034161/0001104659-24-034161-index.htm"},{"fact_type":"ma_transaction","fact_key":"3ea63e58716638b260bf6894b0c320deaa44fcfc","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2024-03-14T23:59:59+00:00","payload":{"action":"acquisition","closing_date":"2024-03-13","consideration_text":null,"counterparty":"ImmunogenX, Inc.","effective_date":"2024-03-13","item_codes_triggered":["2.01"]},"claim":"GridAI Technologies Corp. completed an acquisition involving ImmunogenX, Inc. (closed 2024-03-13).","evidence_excerpt":"On March 13, 2024, the Company completed its business combination with ImmunogenX.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-24-034161","anchor_url":"https://secwatch.observer/filing/0001104659-24-034161#claim-3ea63e58716638b260bf6894b0c320deaa44fcfc","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924034161/0001104659-24-034161-index.htm"},{"fact_type":"material_agreement","fact_key":"62cafb2e3165b0aa715d27b8d69f1b23526fcb18","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2024-03-14T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Merger Agreement","agreement_type":"merger","counterparty":"ImmunogenX","effective_date":null,"item_codes_triggered":["1.01"],"value_text":null},"claim":"GridAI Technologies Corp. entered into Merger Agreement with ImmunogenX.","evidence_excerpt":"Pursuant to the terms of the Merger Agreement, we are required to recommend that our stockholders approve the conversion of shares of our Series G Preferred Stock into shares of our Common Stock.","confidence":0.7,"filing_url":"https://secwatch.observer/filing/0001104659-24-034161","anchor_url":"https://secwatch.observer/filing/0001104659-24-034161#claim-62cafb2e3165b0aa715d27b8d69f1b23526fcb18","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924034161/0001104659-24-034161-index.htm"},{"fact_type":"executive_change","fact_key":"3d5adc9a2f","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2024-03-14T23:59:59+00:00","payload":{"action":"ceased to serve as President","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2024-03-13","interim":false,"role":"President","role_category":"president","successor_name":"Jack Syage","successor_named":true},"claim":"James Sapirstein changed role as President at GridAI Technologies Corp..","evidence_excerpt":"James Sapirstein, the Company’s Chief Executive Officer and Chairman, had served as the Company’s President until the appointment of Dr. Syage.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-24-034161","anchor_url":"https://secwatch.observer/filing/0001104659-24-034161#claim-3d5adc9a2f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924034161/0001104659-24-034161-index.htm"},{"fact_type":"executive_change","fact_key":"8983d1a313","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2024-03-14T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-03-13","interim":false,"role":"Member of the Board","role_category":"director","successor_name":null,"successor_named":false},"claim":"Chaitan Khosla was appointed as Member of the Board at GridAI Technologies Corp..","evidence_excerpt":"appointed (i) Jack Syage, PhD. as the Company’s President and Chief Operating Officer and as a member of the Board and (ii) Chaitan Khosla as a member of the Board","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-24-034161","anchor_url":"https://secwatch.observer/filing/0001104659-24-034161#claim-8983d1a313","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924034161/0001104659-24-034161-index.htm"},{"fact_type":"executive_change","fact_key":"a48470b3ec","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2024-03-14T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-03-13","interim":false,"role":"Member of the Board","role_category":"director","successor_name":null,"successor_named":false},"claim":"Jack Syage was appointed as Member of the Board at GridAI Technologies Corp..","evidence_excerpt":"appointed (i) Jack Syage, PhD. as the Company’s President and Chief Operating Officer and as a member of the Board","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-24-034161","anchor_url":"https://secwatch.observer/filing/0001104659-24-034161#claim-a48470b3ec","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924034161/0001104659-24-034161-index.htm"},{"fact_type":"executive_change","fact_key":"ea1f3d60c1","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2024-03-14T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-03-13","interim":false,"role":"President and Chief Operating Officer","role_category":"president","successor_name":null,"successor_named":false},"claim":"Jack Syage was appointed as President and Chief Operating Officer at GridAI Technologies Corp..","evidence_excerpt":"appointed (i) Jack Syage, PhD. as the Company’s President and Chief Operating Officer and as a member of the Board","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-24-034161","anchor_url":"https://secwatch.observer/filing/0001104659-24-034161#claim-ea1f3d60c1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924034161/0001104659-24-034161-index.htm"},{"fact_type":"material_agreement","fact_key":"9cee35d8507424ca81465c44254c29f6fc9103e4","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2024-03-05T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Purchase Agreement","agreement_type":"equity_purchase","counterparty":"certain purchasers","effective_date":"2024-03-03","item_codes_triggered":["1.01"],"value_text":null},"claim":"GridAI Technologies Corp. entered into Purchase Agreement with certain purchasers (effective 2024-03-03).","evidence_excerpt":"On March 3, 2024, First Wave BioPharma, Inc. (the “Company”) entered into a placement agency agreement (the “Placement Agency Agreement”) with Roth Capital Partners, LLC (the “Placement Agent”) and a securities purchase agreement (the “Purchase Agreement”) with certain purchasers pursuant to which the Company agreed to sell, in a registered direct offering (the “Offering”), an aggregate of (i) 173,100 shares (the “Shares”) of common stock, par value $0.0001 per share (the “Common Stock”), of the Company, and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to an aggregate of 352,525 shares of Common Stock (the “Pre-Funded Warrant Shares”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-24-031098","anchor_url":"https://secwatch.observer/filing/0001104659-24-031098#claim-9cee35d8507424ca81465c44254c29f6fc9103e4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924031098/0001104659-24-031098-index.htm"},{"fact_type":"material_agreement","fact_key":"2b3261def2ee4a4b6f1705f326ee03a68087b14c","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2024-03-05T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Placement Agency Agreement","agreement_type":"underwriting","counterparty":"Roth Capital Partners, LLC","effective_date":"2024-03-03","item_codes_triggered":["1.01"],"value_text":null},"claim":"GridAI Technologies Corp. entered into Placement Agency Agreement with Roth Capital Partners, LLC (effective 2024-03-03).","evidence_excerpt":"On March 3, 2024, First Wave BioPharma, Inc. (the “Company”) entered into a placement agency agreement (the “Placement Agency Agreement”) with Roth Capital Partners, LLC (the “Placement Agent”) and a securities purchase agreement (the “Purchase Agreement”) with certain purchasers pursuant to which the Company agreed to sell, in a registered direct offering (the “Offering”), an aggregate of (i) 173,100 shares (the “Shares”) of common stock, par value $0.0001 per share (the “Common Stock”), of the Company, and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to an aggregate of 352,525 shares of Common Stock (the “Pre-Funded Warrant Shares”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-24-031098","anchor_url":"https://secwatch.observer/filing/0001104659-24-031098#claim-2b3261def2ee4a4b6f1705f326ee03a68087b14c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924031098/0001104659-24-031098-index.htm"},{"fact_type":"governance_change","fact_key":"de6d6bb31079226866e1e13cc03573787c59db53","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2023-12-14T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2023-12-18","item_codes_triggered":["5.03"],"summary_text":"Filed amendment to increase authorized shares and effect a 1-for-20 reverse stock split"},"claim":"GridAI Technologies Corp.: Filed amendment to increase authorized shares and effect a 1-for-20 reverse stock split (effective 2023-12-18).","evidence_excerpt":"On December 13, 2023, the Company filed the Amendment to its Charter with the Secretary of State of the State of Delaware to increase the total number of authorized shares of Common Stock by 50,000,000 shares to 100,000,000 shares and to effect a reverse stock split of its Common Stock at a ratio of 1-to-20 (the “Reverse Stock Split”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-23-125896","anchor_url":"https://secwatch.observer/filing/0001104659-23-125896#claim-de6d6bb31079226866e1e13cc03573787c59db53","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923125896/0001104659-23-125896-index.htm"},{"fact_type":"shareholder_vote","fact_key":"0464c07f2d07b8ff79973db7a632f63186509cb0","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2023-12-14T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-12-12","outcome":"passed","proposal_text":"Approval of the adjournment of the Special Meeting to the extent there are insufficient votes at the Special Meeting to approve any one or more of the foregoing proposals","proposal_type":"other","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"27,691","votes_against":"1,139,463","votes_for":"3,833,578","votes_withheld":null}]},"claim":"GridAI Technologies Corp. shareholders approved Approval of the adjournment of the Special Meeting to the extent there are insufficient votes at the Special Meeting to approve any one or more of the foregoing proposals at the 2023-12-12 meeting.","evidence_excerpt":"The votes were cast for this matter as follows: Votes For Votes Against Abstentions 3,833,578 1,139,463 27,691","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-23-125896","anchor_url":"https://secwatch.observer/filing/0001104659-23-125896#claim-0464c07f2d07b8ff79973db7a632f63186509cb0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923125896/0001104659-23-125896-index.htm"},{"fact_type":"shareholder_vote","fact_key":"ab513a93f6d3aba36d1b96bd1e406cf8bbbd929d","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2023-12-14T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-12-12","outcome":"passed","proposal_text":"Ratification of the Company's entry into a securities purchase agreement on July 18, 2023, with certain purchasers and issuance thereto of an aggregate of 610,000 shares of Common Stock, pre-funded warrants to purchase up to 2,675,000 shares, and common warrants to purchase up to 6,570,000 shares","proposal_type":"auditor_ratification","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"125,522","votes_against":"601,958","votes_for":"1,103,896","votes_withheld":null}]},"claim":"GridAI Technologies Corp. shareholders approved Ratification of the Company's entry into a securities purchase agreement on July 18, 2023, with certain purchasers and issuance thereto of an aggregate of 610,000 shares of Common Stock, pre-funded warrants to purchase up to 2,675,000 shares, and common warrants to purchase up to 6,570,000 shares at the 2023-12-12 meeting.","evidence_excerpt":"The votes were cast for this matter as follows: Votes For Votes Against Abstentions 1,103,896 601,958 125,522","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-23-125896","anchor_url":"https://secwatch.observer/filing/0001104659-23-125896#claim-ab513a93f6d3aba36d1b96bd1e406cf8bbbd929d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923125896/0001104659-23-125896-index.htm"},{"fact_type":"shareholder_vote","fact_key":"289c9704c9b53536cd6e0f62ff6e6abdfd1a3cb3","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2023-12-14T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-12-12","outcome":"passed","proposal_text":"Adoption and approval of the Amendment to the Company's Charter to effect a reverse stock split of the Company's issued and outstanding shares of Common Stock, at a specific ratio, ranging from one-for-ten (1:10) to one-for-twenty (1:20)","proposal_type":"reverse_split","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"16,294","votes_against":"1,581,860","votes_for":"3,402,578","votes_withheld":null}]},"claim":"GridAI Technologies Corp. shareholders approved Adoption and approval of the Amendment to the Company's Charter to effect a reverse stock split of the Company's issued and outstanding shares of Common Stock, at a specific ratio, ranging from one-for-ten (1:10) to one-for-twenty (1:20) at the 2023-12-12 meeting.","evidence_excerpt":"The votes were cast for this matter as follows: Votes For Votes Against Abstentions 3,402,578 1,581,860 16,294","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-23-125896","anchor_url":"https://secwatch.observer/filing/0001104659-23-125896#claim-289c9704c9b53536cd6e0f62ff6e6abdfd1a3cb3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923125896/0001104659-23-125896-index.htm"},{"fact_type":"shareholder_vote","fact_key":"33f7c895210e9e49f4a90fdc2eef7f2a08be9597","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2023-12-14T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-12-12","outcome":"passed","proposal_text":"Adoption and approval of the amendment to our Company's Charter to increase the total number of authorized shares of Common Stock by 50,000,000 shares to 100,000,000 shares","proposal_type":"charter_amendment","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"15,707","votes_against":"1,793,825","votes_for":"3,191,201","votes_withheld":null}]},"claim":"GridAI Technologies Corp. shareholders approved Adoption and approval of the amendment to our Company's Charter to increase the total number of authorized shares of Common Stock by 50,000,000 shares to 100,000,000 shares at the 2023-12-12 meeting.","evidence_excerpt":"The votes were cast for this matter as follows: Votes For Votes Against Abstentions 3,191,201 1,793,825 15,707","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-23-125896","anchor_url":"https://secwatch.observer/filing/0001104659-23-125896#claim-33f7c895210e9e49f4a90fdc2eef7f2a08be9597","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923125896/0001104659-23-125896-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"8b5b1b6090a364603019146f1a98a427fcf1a33b","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2023-10-31T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":null,"deficiency_type":"other","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2023-10-26","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":"Nasdaq Listing Rule 5635(d)","reported_value":null,"rule_numbers":["5635(d)"],"rules_cited_in_text":true},"claim":"GridAI Technologies Corp. received a nasdaq deficiency notice notice regarding other (rules 5635(d)).","evidence_excerpt":"October 26, 2023, First Wave BioPharma, Inc. (the “Company”, “we” or “us”) received written notice\n(the “Notification Letter”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market\nLLC (“Nasdaq”) notifying the Company that it was not in compliance with the shareholder approval requirement set forth in\nNasdaq Listing Rule 5635(d), which requires prior shareholder approval for transactions, other than public offerings, involving the issuance\nof 20% or more of an issuer’s pre-transaction shares outstanding at less than the applicable Minimum Price (as defined in List","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-23-113014","anchor_url":"https://secwatch.observer/filing/0001104659-23-113014#claim-8b5b1b6090a364603019146f1a98a427fcf1a33b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923113014/0001104659-23-113014-index.htm"},{"fact_type":"material_agreement","fact_key":"04441a0c6bfc5f563b2564bac994fafb1c9a4125","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2023-09-14T23:59:59+00:00","payload":{"action":"entry","agreement_name":"License Agreement","agreement_type":"license","counterparty":"Sanofi","effective_date":"2023-09-13","item_codes_triggered":["1.01"],"value_text":"upfront payment of $500,000"},"claim":"GridAI Technologies Corp. entered into License Agreement with Sanofi valued at upfront payment of $500,000 (effective 2023-09-13).","evidence_excerpt":"On September 13, 2023, First Wave BioPharma, Inc. (the “Company”) entered into a License Agreement (the “License Agreement”) with Sanofi (“Sanofi”), pursuant to which the Company received a license to obtain certain exclusive worldwide rights to develop and commercialize Capeserod","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-23-100614","anchor_url":"https://secwatch.observer/filing/0001104659-23-100614#claim-04441a0c6bfc5f563b2564bac994fafb1c9a4125","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923100614/0001104659-23-100614-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"f03ded757ad4282579359c67e8376509fcbc16be","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2023-08-25T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":"2024-02-20","deficiency_type":"minimum_bid_price","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2023-08-24","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5550(a)(2)","5810(c)(3)(A)"],"rules_cited_in_text":true},"claim":"GridAI Technologies Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"August 24, 2023, First\nWave BioPharma, Inc. (the “Company”) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC\n(“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock, par value $0.0001 per share\n(“Common Stock”), for the last 30 consecutive business days, the Company is not currently in compliance with the requirement\nto maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing\nRule 5550(a)(2) (the “Notice”). The Notice has no immediate\neffect on the","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-23-095325","anchor_url":"https://secwatch.observer/filing/0001104659-23-095325#claim-f03ded757ad4282579359c67e8376509fcbc16be","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923095325/0001104659-23-095325-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"e471c72548cab8c590c60026302c2952edd024ff","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2023-08-18T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":"2024-02-13","deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"$2.5 million","notice_date":"2023-08-17","notice_type":"deficiency_notice","plan_due_date":"2023-10-02","raw_rule_text":null,"reported_value":"$881,960","rule_numbers":["5550(b)(1)"],"rules_cited_in_text":true},"claim":"GridAI Technologies Corp. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"August 17, 2023, First Wave BioPharma, Inc.\n(the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock\nMarket LLC (“Nasdaq”) indicating that the Company was not in compliance with the minimum stockholders’ equity requirement\nfor continued listing on The Nasdaq Capital Market, under Listing Rule 5550(b)(1), because the Company’s stockholders’ equity\nof $881,960 as reported in the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2023 was below the required\nminimum of $2.5 million, and because, as of June 30, 2023, the Comp","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-23-093483","anchor_url":"https://secwatch.observer/filing/0001104659-23-093483#claim-e471c72548cab8c590c60026302c2952edd024ff","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923093483/0001104659-23-093483-index.htm"},{"fact_type":"material_agreement","fact_key":"fe86b4b3b5f7f8505a0acb1cb1d507a8242524d5","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2023-07-21T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Purchase Agreement","agreement_type":"equity_purchase","counterparty":"certain purchasers","effective_date":"2023-07-18","item_codes_triggered":["1.01"],"value_text":"approximately $1.8 million"},"claim":"GridAI Technologies Corp. entered into Purchase Agreement with certain purchasers valued at approximately $1.8 million (effective 2023-07-18).","evidence_excerpt":"ith Roth Capital Partners, LLC (the “Placement Agent”) and a securities purchase agreement (the “Purchase Agreement”)\nwith certain purchasers pursuant to which the Company agreed to sell, in a best efforts public offering (the “Offering”),","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-23-082895","anchor_url":"https://secwatch.observer/filing/0001104659-23-082895#claim-fe86b4b3b5f7f8505a0acb1cb1d507a8242524d5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923082895/0001104659-23-082895-index.htm"},{"fact_type":"material_agreement","fact_key":"0a84db89a1b17e6f2a5fccf920c3ac078a010e9c","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2023-07-21T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Placement Agency Agreement","agreement_type":"underwriting","counterparty":"Roth Capital Partners, LLC","effective_date":"2023-07-18","item_codes_triggered":["1.01"],"value_text":null},"claim":"GridAI Technologies Corp. entered into Placement Agency Agreement with Roth Capital Partners, LLC (effective 2023-07-18).","evidence_excerpt":"On July 18, 2023, First Wave BioPharma, Inc. (the “Company”) entered into a placement agency agreement (the “Placement Agency Agreement”) with Roth Capital Partners, LLC (the “Placement Agent”)","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-23-082895","anchor_url":"https://secwatch.observer/filing/0001104659-23-082895#claim-0a84db89a1b17e6f2a5fccf920c3ac078a010e9c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923082895/0001104659-23-082895-index.htm"},{"fact_type":"shareholder_vote","fact_key":"248ff734197ed3e23a46a626d6c1e4d595b5e277","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2023-06-23T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-06-22","outcome":"passed","proposal_text":"Adjournment of Annual Meeting if insufficient proxies to approve proposals","proposal_type":"other","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"15,382","votes_against":"164,471","votes_for":"718,960","votes_withheld":null}]},"claim":"GridAI Technologies Corp. shareholders approved Adjournment of Annual Meeting if insufficient proxies to approve proposals at the 2023-06-22 meeting.","evidence_excerpt":"The stockholders approved the adjournment of the Annual Meeting to the extent that there were insufficient proxies at the Annual Meeting to approve any one or more of the foregoing proposals.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-23-074236","anchor_url":"https://secwatch.observer/filing/0001104659-23-074236#claim-248ff734197ed3e23a46a626d6c1e4d595b5e277","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923074236/0001104659-23-074236-index.htm"},{"fact_type":"shareholder_vote","fact_key":"74a4972d86bdecd25f887d2d52b1219f3ed3288b","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2023-06-23T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-06-22","outcome":"passed","proposal_text":"Ratification of appointment of Mazars USA LLP as independent registered public accounting firm for fiscal year ending December 31, 2023","proposal_type":"auditor_ratification","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"27,661","votes_against":"64,399","votes_for":"806,755","votes_withheld":null}]},"claim":"GridAI Technologies Corp. shareholders approved Ratification of appointment of Mazars USA LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-06-22 meeting.","evidence_excerpt":"The stockholders approved the ratification of the appointment of Mazars USA LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2023.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-23-074236","anchor_url":"https://secwatch.observer/filing/0001104659-23-074236#claim-74a4972d86bdecd25f887d2d52b1219f3ed3288b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923074236/0001104659-23-074236-index.htm"},{"fact_type":"shareholder_vote","fact_key":"3e15f0ca78685fe7b9b7d7145d53519b50c86e6c","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2023-06-23T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-06-22","outcome":"passed","proposal_text":"Advisory vote on executive compensation","proposal_type":"say_on_pay","results":[{"broker_non_votes":"479,278","subject":null,"votes_abstain":"4,659","votes_against":"128,673","votes_for":"286,205","votes_withheld":null}]},"claim":"GridAI Technologies Corp. shareholders approved Advisory vote on executive compensation at the 2023-06-22 meeting.","evidence_excerpt":"The stockholders voted to approve, on an advisory basis, the executive compensation of the Company’s named executive officers as described in the Proxy Statement.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-23-074236","anchor_url":"https://secwatch.observer/filing/0001104659-23-074236#claim-3e15f0ca78685fe7b9b7d7145d53519b50c86e6c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923074236/0001104659-23-074236-index.htm"},{"fact_type":"shareholder_vote","fact_key":"620cb69f8657582940ced4ebe21d625560153f13","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2023-06-23T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-06-22","outcome":"passed","proposal_text":"Amendment to 2020 Omnibus Equity Incentive Plan to increase authorized shares and increase incentive stock option limit","proposal_type":"equity_plan","results":[{"broker_non_votes":"479,278","subject":null,"votes_abstain":"1,408","votes_against":"136,277","votes_for":"281,852","votes_withheld":null}]},"claim":"GridAI Technologies Corp. shareholders approved Amendment to 2020 Omnibus Equity Incentive Plan to increase authorized shares and increase incentive stock option limit at the 2023-06-22 meeting.","evidence_excerpt":"The stockholders voted to approve an amendment to the Company’s 2020 Omnibus Equity Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder from 317,480 to 1,167,480 and to increase the number of shares that otherwise become available under the plan for grants as incentive stock options to 5,000,000.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-23-074236","anchor_url":"https://secwatch.observer/filing/0001104659-23-074236#claim-620cb69f8657582940ced4ebe21d625560153f13","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923074236/0001104659-23-074236-index.htm"},{"fact_type":"shareholder_vote","fact_key":"d588f081cd85b29c6b6055e31c1f7143bffa0196","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2023-06-23T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-06-22","outcome":"passed","proposal_text":"Election of directors","proposal_type":"director_election","results":[{"broker_non_votes":"479,278","subject":"James Sapirstein","votes_abstain":null,"votes_against":null,"votes_for":"341,989","votes_withheld":"77,548"},{"broker_non_votes":"479,278","subject":"Edward J. Borkowski","votes_abstain":null,"votes_against":null,"votes_for":"381,741","votes_withheld":"37,796"},{"broker_non_votes":"479,278","subject":"Charles J. Casamento","votes_abstain":null,"votes_against":null,"votes_for":"318,303","votes_withheld":"101,234"},{"broker_non_votes":"479,278","subject":"Terry Coelho","votes_abstain":null,"votes_against":null,"votes_for":"370,182","votes_withheld":"49,355"},{"broker_non_votes":"479,278","subject":"Alastair Riddell","votes_abstain":null,"votes_against":null,"votes_for":"330,357","votes_withheld":"89,180"}]},"claim":"GridAI Technologies Corp. shareholders approved Election of directors at the 2023-06-22 meeting.","evidence_excerpt":"The stockholders elected each of James Sapirstein, Edward J. Borkowski, Charles J. Casamento, Terry Coelho and Alastair Riddell to serve on the Company’s board of directors for a term of one year expiring at the annual meeting of stockholders to be held in 2024 or until their respective successors are duly elected and qualified.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-23-074236","anchor_url":"https://secwatch.observer/filing/0001104659-23-074236#claim-d588f081cd85b29c6b6055e31c1f7143bffa0196","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923074236/0001104659-23-074236-index.htm"},{"fact_type":"material_agreement","fact_key":"40076cc04cf57205dbb405b16d4ff47a96ed1a74","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2023-03-15T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Registration Rights Agreement","agreement_type":"other","counterparty":"the Purchaser","effective_date":"2023-03-12","item_codes_triggered":["1.01"],"value_text":null},"claim":"GridAI Technologies Corp. entered into Registration Rights Agreement with the Purchaser (effective 2023-03-12).","evidence_excerpt":"In connection with the Offering, on March 12, 2023, the Company and the Purchaser entered into a Registration Rights Agreement (the \"Registration Rights Agreement\") pursuant to which the Company is required to file a registration statement with the Securities and Exchange Commission (the \"SEC\") to register for resale the Shares and the Warrant Shares.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-23-032650","anchor_url":"https://secwatch.observer/filing/0001104659-23-032650#claim-40076cc04cf57205dbb405b16d4ff47a96ed1a74","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923032650/0001104659-23-032650-index.htm"},{"fact_type":"material_agreement","fact_key":"2db8fc2d57d904dc76e2871cfdc92ae9c6dc2915","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2023-03-15T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"a single institutional investor","effective_date":"2023-03-12","item_codes_triggered":["1.01"],"value_text":"approximately $4.0 million"},"claim":"GridAI Technologies Corp. entered into Securities Purchase Agreement with a single institutional investor valued at approximately $4.0 million (effective 2023-03-12).","evidence_excerpt":"On March 12, 2023, First Wave BioPharma, Inc., a Delaware corporation (the \"Company\"), entered into a Securities Purchase Agreement (the \"Purchase Agreement\") with a single institutional investor (the \"Purchaser\"), pursuant to which the Company agreed to issue, in a private placement (the \"Offering\"), an aggregate of (i) 128,000 shares (the \"Shares\") of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), (ii) pre-funded warrants (the \"Pre-Funded Warrants\") to purchase up to an aggregate of 895,018 shares (the \"Pre-Funded Warrant Shares\") and (iii) common warrants (the \"Common Warrants\" and collectively with the Pre-Funded Warrants, the \"Warrants\"), to purchase up to an aggregate of 2,046,036 shares of Common Stock (the \"Common Warrant Shares\" and collectively with the Pre-Funded Warrant Shares, the \"Warrant Shares\") at a purchase price of $3.91 per Share (or Pre-Funded Warrant in lieu thereof) and accompanying Common Warrant.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-23-032650","anchor_url":"https://secwatch.observer/filing/0001104659-23-032650#claim-2db8fc2d57d904dc76e2871cfdc92ae9c6dc2915","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923032650/0001104659-23-032650-index.htm"},{"fact_type":"governance_change","fact_key":"63d760121c7ca2011bf68209849fa4dd3c7fa5aa","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2023-01-17T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2023-01-18","item_codes_triggered":["5.03"],"summary_text":"Amended charter to effect a 1-for-7 reverse stock split"},"claim":"GridAI Technologies Corp.: Amended charter to effect a 1-for-7 reverse stock split (effective 2023-01-18).","evidence_excerpt":"On January 13, 2023, the Company filed the Amendment to its Charter with the Secretary of State of the State of Delaware to effect a reverse stock split of its Common Stock at a ratio of 1-to-7 (the “Reverse Stock Split”). The Reverse Stock Split will become effective in accordance with the terms of the Amendment at 12:01 AM Eastern Time on January 18, 2023 (the “Effective Time”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-23-004102","anchor_url":"https://secwatch.observer/filing/0001104659-23-004102#claim-63d760121c7ca2011bf68209849fa4dd3c7fa5aa","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923004102/0001104659-23-004102-index.htm"},{"fact_type":"shareholder_vote","fact_key":"ce4d7caacb44d53deb610abfd2959515baa1f09f","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2023-01-17T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-01-13","outcome":"passed","proposal_text":"Approval of the adjournment of the Special Meeting to the extent there are insufficient votes at the Special Meeting to approve any one or more of the foregoing proposals","proposal_type":"other","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"166,566,900","votes_against":"592,147,779","votes_for":"1,584,130,826","votes_withheld":null}]},"claim":"GridAI Technologies Corp. shareholders approved Approval of the adjournment of the Special Meeting to the extent there are insufficient votes at the Special Meeting to approve any one or more of the foregoing proposals at the 2023-01-13 meeting.","evidence_excerpt":"3. The Adjournment Proposal. The votes were cast for this matter as follows: Votes For Votes Against Abstentions 1,584,130,826 592,147,779 166,566,900","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-23-004102","anchor_url":"https://secwatch.observer/filing/0001104659-23-004102#claim-ce4d7caacb44d53deb610abfd2959515baa1f09f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923004102/0001104659-23-004102-index.htm"},{"fact_type":"shareholder_vote","fact_key":"d42d37161da9bd0a63b610fb0730a112dbcf1ebc","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2023-01-17T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-01-13","outcome":"passed","proposal_text":"Adoption and approval of the Amendment to the Company’s Charter to effect a reverse stock split of the Company’s issued and outstanding shares of Common Stock, at a specific ratio, ranging from one-for-three (1:3) to one-for-forty (1:40)","proposal_type":"reverse_split","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"142,979,935","votes_against":"574,231,665","votes_for":"1,625,633,905","votes_withheld":null}]},"claim":"GridAI Technologies Corp. shareholders approved Adoption and approval of the Amendment to the Company’s Charter to effect a reverse stock split of the Company’s issued and outstanding shares of Common Stock, at a specific ratio, ranging from one-for-three (1:3) to one-for-forty (1:40) at the 2023-01-13 meeting.","evidence_excerpt":"2. The Reverse Stock Split Proposal. The votes were cast for this matter as follows: Votes For Votes Against Abstentions 1,625,633,905 574,231,665 142,979,935","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-23-004102","anchor_url":"https://secwatch.observer/filing/0001104659-23-004102#claim-d42d37161da9bd0a63b610fb0730a112dbcf1ebc","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923004102/0001104659-23-004102-index.htm"},{"fact_type":"shareholder_vote","fact_key":"0869369efc31d0e36f72103849c59a6281da43be","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2023-01-17T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-01-13","outcome":"passed","proposal_text":"Approval of the issuance of more than 20% of our Common Stock pursuant to the private placement and warrant amendment for purposes of Nasdaq Listing Rule 5635(d)","proposal_type":"other","results":[{"broker_non_votes":"1,262,765","subject":null,"votes_abstain":"52,341","votes_against":"496,698","votes_for":"528,701","votes_withheld":null}]},"claim":"GridAI Technologies Corp. shareholders approved Approval of the issuance of more than 20% of our Common Stock pursuant to the private placement and warrant amendment for purposes of Nasdaq Listing Rule 5635(d) at the 2023-01-13 meeting.","evidence_excerpt":"1. The Private Placement Proposal. The votes were cast for this matter as follows: Votes For Votes Against Abstentions Broker Non-Votes 528,701 496,698 52,341 1,262,765","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-23-004102","anchor_url":"https://secwatch.observer/filing/0001104659-23-004102#claim-0869369efc31d0e36f72103849c59a6281da43be","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923004102/0001104659-23-004102-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"da9a0c52acf1a65a82b6a71d29190c22aa1b6139","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2022-12-16T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":null,"deficiency_type":"minimum_bid_price","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"$1.00 per share","notice_date":"2022-12-14","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":"Nasdaq Listing Rule 5550(a)(2)","reported_value":null,"rule_numbers":["5550(a)(2)","5810(3)(A)(iv)"],"rules_cited_in_text":true},"claim":"GridAI Technologies Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(3)(A)(iv)).","evidence_excerpt":"December 14, 2022, First\nWave BioPharma, Inc. (the “Company”) received a deficiency notice from the Listing Qualifications Staff (the “Staff”)\nof The Nasdaq Stock Market LLC (“Nasdaq”), indicating that, based upon the closing bid price of the Company’s common\nstock, par value $0.0001 per share (the “Common Stock”), for the prior 30 consecutive business days, the Company was not in\ncompliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market,\nas set forth in Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). The Staff","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-22-127875","anchor_url":"https://secwatch.observer/filing/0001104659-22-127875#claim-da9a0c52acf1a65a82b6a71d29190c22aa1b6139","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465922127875/0001104659-22-127875-index.htm"},{"fact_type":"material_agreement","fact_key":"b8db4e3a9ad7f964bc64267d527eb67022b921a3","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2022-12-02T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Settlement Agreement","agreement_type":"settlement","counterparty":"Fortis Advisors LLC and certain individuals","effective_date":"2022-11-30","item_codes_triggered":["1.01"],"value_text":null},"claim":"GridAI Technologies Corp. entered into Settlement Agreement with Fortis Advisors LLC and certain individuals (effective 2022-11-30).","evidence_excerpt":"Effective November 30, 2022, the Company, the Representative and certain individuals entered into a settlement agreement (the “Settlement Agreement”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-22-124092","anchor_url":"https://secwatch.observer/filing/0001104659-22-124092#claim-b8db4e3a9ad7f964bc64267d527eb67022b921a3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465922124092/0001104659-22-124092-index.htm"},{"fact_type":"material_agreement","fact_key":"eed6ce3129ed6f867cb894dd0d38d5d05cbc07a6","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2022-11-22T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Warrant Amendment Agreement","agreement_type":"equity_purchase","counterparty":null,"effective_date":"2022-11-20","item_codes_triggered":["1.01"],"value_text":null},"claim":"GridAI Technologies Corp. amended Warrant Amendment Agreement (effective 2022-11-20).","evidence_excerpt":"In connection with the Offering, the Company entered into a warrant amendment agreement (the “Warrant Amendment Agreement”) with the Purchaser pursuant to which the Company agreed to amend the Purchaser’s existing warrants to purchase up to 3,736,990 shares of Common Stock at a weighted average exercise price of $4.21 per share (the “Existing Warrants”), in consideration for such Purchaser’s purchase of $2.5 million of securities in the Offering (the “Purchase Commitment”), to (i) lower the exercise price of the Existing Warrants to $0.7685 per share and (ii) extend the termination date of the Existing Warrants until the five and one-half year anniversary of the Stockholder Approval (the “Warrant Amendment”), effective upon the consummation of the Offering and confirmation by the Placement Agent that the Purchaser has satisfied the Purchase Commitment.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-22-121003","anchor_url":"https://secwatch.observer/filing/0001104659-22-121003#claim-eed6ce3129ed6f867cb894dd0d38d5d05cbc07a6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465922121003/0001104659-22-121003-index.htm"},{"fact_type":"material_agreement","fact_key":"a3a4df3af4f0f62aaae31043bdfe8c0a00016e39","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2022-11-22T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":null,"effective_date":"2022-11-20","item_codes_triggered":["1.01"],"value_text":"approximately $2.5 million"},"claim":"GridAI Technologies Corp. entered into Securities Purchase Agreement valued at approximately $2.5 million (effective 2022-11-20).","evidence_excerpt":"On November 20, 2022, First Wave BioPharma, Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a single institutional investor (the “Purchaser”), pursuant to which the Company agreed to issue, in a private placement (the “Offering”), an aggregate of (i) pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to an aggregate of 4,166,667 shares (the “Pre-Funded Warrant Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), and (ii) common warrants (the “Common Warrants” and collectively with the Pre-Funded Warrants, the “Warrants”), to purchase up to an aggregate of 8,333,334 shares of Common Stock (the “Common Warrant Shares” and collectively with the Pre-Funded Warrant Shares, the “Warrant Shares”) at a purchase price of $0.5999 per Pre-Funded Warrant and accompanying Common Warrant.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-22-121003","anchor_url":"https://secwatch.observer/filing/0001104659-22-121003#claim-a3a4df3af4f0f62aaae31043bdfe8c0a00016e39","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465922121003/0001104659-22-121003-index.htm"},{"fact_type":"executive_change","fact_key":"d46bbcd05e","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2022-06-17T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2022-06-16","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Gregory Oakes resigned as Director at GridAI Technologies Corp..","evidence_excerpt":"On June 16, 2022, Gregory Oakes submitted his resignation from the Board of Directors (the “Board”) of First Wave BioPharma, Inc. (the “Company”), effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-22-072444","anchor_url":"https://secwatch.observer/filing/0001104659-22-072444#claim-d46bbcd05e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465922072444/0001104659-22-072444-index.htm"},{"fact_type":"executive_change","fact_key":"9c5e7fb9c0","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2022-04-29T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-04-27","interim":false,"role":"Member of the Board","role_category":"director","successor_name":null,"successor_named":false},"claim":"David Hoffman was appointed as Member of the Board at GridAI Technologies Corp..","evidence_excerpt":"approved, effective immediately, an increase in the size of the Board from six directors to seven directors and appointed David Hoffman, age 61, to serve as a member of the Board to fill the newly-created vacancy.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001140361-22-017051","anchor_url":"https://secwatch.observer/filing/0001140361-22-017051#claim-9c5e7fb9c0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000114036122017051/0001140361-22-017051-index.htm"},{"fact_type":"executive_change","fact_key":"d7e45bb4b3","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2022-04-06T23:59:59+00:00","payload":{"action":"retired","action_category":"departure","departure_tone":"retirement","effective_date":"2022-03-31","interim":false,"role":"Chief Medical Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"James Pennington, M.D. retired as Chief Medical Officer at GridAI Technologies Corp..","evidence_excerpt":"On March 31, 2022, James Pennington, M.D., Chief Medical Officer of First Wave BioPharma, Inc. (the “Company”), informed the Company of his intention to retire as Chief Medical Officer.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001140361-22-013398","anchor_url":"https://secwatch.observer/filing/0001140361-22-013398#claim-d7e45bb4b3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000114036122013398/0001140361-22-013398-index.htm"},{"fact_type":"executive_change","fact_key":"96434b98ec","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2022-02-17T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-03-01","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Sarah Romano was appointed as Chief Financial Officer at GridAI Technologies Corp..","evidence_excerpt":"Sarah Romano, CPA, has been appointed to serve as the Chief Financial Officer of the Company, effective March 1, 2022.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001140361-22-005873","anchor_url":"https://secwatch.observer/filing/0001140361-22-005873#claim-96434b98ec","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000114036122005873/0001140361-22-005873-index.htm"},{"fact_type":"executive_change","fact_key":"5705379eb2","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2022-02-17T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2022-02-28","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":"Sarah Romano","successor_named":true},"claim":"Daniel Schneiderman resigned as Chief Financial Officer at GridAI Technologies Corp..","evidence_excerpt":"On February 14, 2022, Daniel Schneiderman, the Chief Financial Officer of the Company, notified the Company that he will resign as Chief Financial Officer effective as of February 28, 2022 (the “Termination Date”) to pursue additional opportunities.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001140361-22-005873","anchor_url":"https://secwatch.observer/filing/0001140361-22-005873#claim-5705379eb2","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000114036122005873/0001140361-22-005873-index.htm"},{"fact_type":"executive_change","fact_key":"98c3593577","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2021-11-09T23:59:59+00:00","payload":{"action":"will not stand for re-election","action_category":"departure","departure_tone":"routine","effective_date":"2021-12-17","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Vern Lee Schramm departed as Director at GridAI Technologies Corp..","evidence_excerpt":"On November 4, 2021, Vern Lee Schramm, Ph.D., provided notice to the Board of Directors of First Wave BioPharma, Inc. (the “Company”), that he would not stand for re-election as director at the Company’s upcoming annual meeting of stockholders (the “Annual Meeting”), currently scheduled for December 17, 2021.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001851734-21-000052","anchor_url":"https://secwatch.observer/filing/0001851734-21-000052#claim-98c3593577","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000185173421000052/0001851734-21-000052-index.htm"},{"fact_type":"executive_change","fact_key":"e1eec55554","cik":1604191,"ticker":"GRDX","company_name":"GridAI Technologies Corp.","filed_at":"2021-08-16T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2021-08-11","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Terry Coelho was appointed as Director at GridAI Technologies Corp..","evidence_excerpt":"On August 11, 2021, the Board of Directors (the “Board”) of AzurRx BioPharma, Inc. (the “Company”) approved, effective immediately, an increase in the size of the Board from six directors to seven directors and appointed Terry Coelho, age 60, to serve as a member of the Board to fill the newly-created vacancy.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001654954-21-009075","anchor_url":"https://secwatch.observer/filing/0001654954-21-009075#claim-e1eec55554","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1604191/000165495421009075/0001654954-21-009075-index.htm"}]}